AUTHOREA
Log in Sign Up Browse Preprints
Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

REACTIVATION OF HERPES ZOSTER AFTER VACCINATION WITH AN INACTIVATED VACCINE: A CASE REPORT FROM NEPAL
  • +3
  • SANGAM SHAH,
  • Bikash Baral,
  • Rajan Chamlagain,
  • Hritik Murarka,
  • Yagya Adhikari,
  • Basanta Sharma Paudel
SANGAM SHAH
Maharajgunj Medical Campus, Institute of Medicine

Corresponding Author:[email protected]

Author Profile
Bikash Baral
Tribhuvan University Institute of Medicine
Author Profile
Rajan Chamlagain
Tribhuvan University Teaching Hospital
Author Profile
Hritik Murarka
Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University, Maharajgunj, 44600, Nepal
Author Profile
Yagya Adhikari
Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University
Author Profile
Basanta Sharma Paudel
Tribhuvan University Teaching Hospital
Author Profile

Abstract

COVID-19 has been linked to a number of cutaneous symptoms in COVID-19 patients. Although herpes zoster (HZ) was the first sign of COVID-19 infection in several patients, cases of HZ after COVID-19 vaccination are rare. We report case of 51 years old male with Herpes Zoster after Sinopharm (Vero Cell).

Peer review status:Published

04 Sep 2021Submitted to Clinical Case Reports
Show details
Hide details
07 Sep 2021Submission Checks Completed
07 Sep 2021Assigned to Editor
26 Sep 2021Reviewer(s) Assigned
11 Oct 2021Review(s) Completed, Editorial Evaluation Pending
17 Oct 2021Editorial Decision: Revise Minor
17 Oct 20211st Revision Received
19 Oct 2021Submission Checks Completed
19 Oct 2021Assigned to Editor
19 Oct 2021Review(s) Completed, Editorial Evaluation Pending
06 Nov 2021Editorial Decision: Revise Minor
12 Nov 20212nd Revision Received
12 Nov 2021Submission Checks Completed
12 Nov 2021Assigned to Editor
12 Nov 2021Review(s) Completed, Editorial Evaluation Pending
14 Nov 2021Editorial Decision: Revise Minor
20 Nov 20213rd Revision Received
20 Nov 2021Submission Checks Completed
20 Nov 2021Assigned to Editor
20 Nov 2021Review(s) Completed, Editorial Evaluation Pending
25 Nov 2021Editorial Decision: Accept
Dec 2021Published in Clinical Case Reports volume 9 issue 12. 10.1002/ccr3.5188